You have 9 free searches left this month | for more free features.

City

Condition

Carcinoma, Non-small Cell Lung (1)

Overall Status

Withdrawn (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Novartis Pharmaceuticals (1)

Collaborator

Intervention

efg816 (1)

erlotinib or gefitinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

efg816

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Carcinoma, Non-small Cell Lung Trial (EFG816, erlotinib or gefitinib)

Withdrawn

Carcinoma, Non-small Cell Lung

EFG816
erlotinib or gefitinib

(no location specified)

Nov 21, 2019